Researchers from the US and Australia have launched a new collaboration to solve childhood heart disease.

The global research program involves the Murdoch Children’s Research Institute (MCRI) in Melbourne and the Gladstone Institutes in San Francisco, with researchers working to identify the genetic causes of childhood heart disease and develop new treatments using stem cells and artificial intelligence technology. .

“These types of approaches will really allow us to identify the underlying causes of childhood heart disease so that we can intervene early with targeted treatments that prevent the heart from failing and prevent the need for a transplant,” said Professor Enzo Porrello, director of Stem. Murdoch Children’s Research Institute Cellular Medicine, said in an interview with WNYW FOX 5 New York.

Researchers are developing miniature heart tissues from stem cells, helping them understand the underlying causes of childhood heart disease and develop new treatments.

Porrello said AI will play a very important role in your research.

“We can really generate enormous amounts of data that tell us how the heart might respond to different genetic causes of heart disease, how an individual’s heart might respond to a particular drug or a new treatment. And then we can use these tools to predict and tailor the right drug to the right patient,” he added.

MCRI’s stem cell expertise combined with Gladstone Institutes’ artificial intelligence expertise is ushering in a new era of pediatric medicine.